Page 135 - Health Medical Pharma
Parrikar discharged from hospital
Ailing Goa Chief Minister Manohar Parrikar was Tuesday discharged from the Goa Medical College and Hospital (GMCH) near here, where he was admitted on Saturday, a senior official said. Parrikar, 63, was admitted to the GMCH for treatment of his pancreatic ailment. "The CM has been discharged from the GMCH. He has gone to his residence at Dona Paula," the official from the Chief Minister's Office (CMO) said. Parrikar was treated by a team of doctors from the New Delhi-based All India Institute of Medical Sciences (AIIMS), as well as doctors from the GMCH, the official added. Parrikar has been ailing for the last one year and has undergone treatment in the US as well as at AIIMS Delhi, besides hospitals in Mumbai and Goa.
Indian Cardiologist broadcasts live surgery on 3 critical blockages for doctors gathered in Singapore
Renowned Cardiologist Dr. Ganesh Kumar at Mumbai based Dr. L H Hiranandani Hospital recently conducted Live Case Demonstration to Singapore for a Conference called 'Singapore Live' in which 100's of Cardiologists from across the world participated. Doctors in Singapore could watch the critical Live Case Demo via satellite transmission.About two hour long Live Surgery was performed by Cardiologists - Dr. Ganesh Kumar and Dr. Irfan Khan of Dr. L H Hiranandani Hospital in Mumbai on Kolhapur based farmer - Deepak Bandekar, 55 years old, while hundreds of doctors gathered in Singapore for a conference watched it.This patient had suffered a cardiac arrest and was diagnosed with three critical blockages stuck in very thin arteries due to which many hospitals had refused to operate on this patient. The Cardiologists at L H Hiranandani Hospital took up this challenge and skilfully used 1.5 to 2 mm stents to clear those blockages successfully.While speaking about Live Surgery Dr. Ganesh Kumar ..
Gujarat based Espee Group gets USFDA approval for their manufacturing plant in USA
Aavis Pharmaceuticals, part of Espee Group, located in Hoschton, GA, completed an inspection by the US Food and Drug Administration at the company's primary manufacturing facility with Zero 483 observations. With successful inspection of its formulation manufacturing plant Espee becomes the 3rd Group in Gujarat to have USFDA approved plant in USA.The company's formulations facility was inspected by the USFDA for good manufacturing practices and PAI (Pre-Approval Inspection) in January 2019. Aavis Pharma said it received the Establishment Inspection Report (EIR) in February 2019, which concludes the inspection process."It is a moment of great pride and a massive step forward towards the long-term strategy of our group and we congratulate the entire team at Aavis for successfully clearing its first inspection with zero 483 observations," saidSwapnil Shah, Executive Director of Espee Group and Ashok Barot, Chairman of Aavis Pharmaceuticals.He added that, "AAVIS Pharmaceuticals is one of .
Can Google Translate be trusted for medical advice?
Google can aptly translate doctor's orders into Spanish and Chinese albeit with a few significant errors, finds a study.
New mothers tend to suffer disrupted sleep for 6 years: Study
While birth of a child is a matter of joy to parents, it has drastic effects on first-time mothers' sleep for up to six years, finds a study.
Lupin launches acne symptoms treatment tablets in US
Drug firm Lupin Tuesday said it has launched in the US Minocycline Hydrochloride extended-release tablets, used for treatment of inflammatory lesions of acne. The company has launched Minocycline Hydrochloride extended-release tablets USP in the strength of 55 mg, after receiving an approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said. As per IQVIA MAT December 2018 data, the product had annual sales of around USD 76.8 million in the US, Lupin said. The product is a generic version of Medicis Pharmaceutical Corporation's Solodyn tablets in the same strength, it added. The tablets are indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older, it added. Shares of Lupin closed at Rs 773.40 per scrip on BSE, down 0.41 per cent from the previous close.
'Lab-on-a-chip' detects cancer faster: Study
Scientists have developed a "lab-on-a-chip" may allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to timelier interventions and better outcomes for patients. The ultrasensitive diagnostic device, developed by researchers at University of Kansas in the US, detects exosomes -- tiny parcels of biological information produced by tumour cells to stimulate tumour growth or metastasize. "Historically, people thought exosomes were like 'trash bags' that cells could use to dump unwanted cellular contents," said Yong Zeng, an associate professor at KU. "But in the past decade, scientists realised they were quite useful for sending messages to recipient cells and communicating molecular information important in many biological functions," said Zeng. "Basically, tumours send out exosomes packaging active molecules that mirror the biological features of the parental cells. While all cells produce exosomes, tumour cells are really active compared to normal cells," he
New microfluidics device can detect cancer cells in blood
Researchers have now developed a device that can isolate individual cancer cells from patient blood samples.The research was carried out by researchers from the University of Illinois Chicago and Queensland University of Technology of Australia.The microfluidics device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans.The findings are reported in the journal Microsystems & Nanoengineering.Speaking about it, corresponding author of the study, said, "This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood," adding, "While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn't require much specimen preparation or dilution, making it fast and easy to ...
New lab-on-a-chip device to detect cancer faster
In a breakthrough, US researchers have developed a "lab-on-a-chip" device that allows doctors to detect cancer faster, cheaper and less invasively from a droplet of blood or plasma, leading to timely interventions and better outcome for patients.
Urban parks boost happiness: Study
Spending 20 minutes in an urban park will make someone happier regardless of whether they engage in exercise during the visit, a study has found. According to the study, published in International Journal of Environmental Health Research, urban parks have been recognised as key neighbourhood places that provide residents with opportunities to experience nature and engage in various activities. Through contact with the natural environment and engagement in health-promoting and/or social and recreational activities in parks, users experience physical and mental health benefits such as stress reduction and recovery from mental fatigue. The original intent of the project was to validate previous research findings on the impact of park visit on emotional well-being, and evaluate the contribution of choosing to participate in physical activity in the park in relation to emotional well-being after the park visit. "Overall, we found park visitors reported an improvement in emotional ...
New parents face up to six years of disrupted sleep
Having a baby disrupts sleep quality of the new parents for up to six years after the child's birth, a study has found. Researchers at the University of Warwick in the UK studied sleep in 4,659 parents who had a child between 2008 and 2015. During these years parents also reported on their sleep in yearly interviews. In the first three months after birth mothers slept on average one hour less than before pregnancy while fathers sleep duration decreased by approximately 15 minutes, researchers said in a statements. The study shows that after birth of the first child and up to six years after birth mothers and fathers sleep duration and sleep satisfaction do not fully recover to the levels before pregnancy. "Women tend to experience more sleep disruption than men after the birth of a child reflecting that mothers are still more often in the role of the primary caregiver than fathers," said Sakari Lemola, from the University of Warwick. However, when the children were 4-6 years old sleep
Discovery of colon cancer pathway could lead to new targeted treatments
A new study, conducted by food science researchers at the University of Massachusetts have found a set of enzymes involved in tumour growth that could be targeted to prevent or treat colon cancer.Speaking about it, study author Guosong Zhang said, "Our research identifies a novel therapeutic target and could help to develop novel strategies to reduce the risks of colon cancer."The study was published in the journal Cancer Research.In their study, UMass Amherst researchers tested their hypothesis that once present, colon cancer was increased by enzymes known as cytochrome P450 (CYP) monooxygenases and the fatty acid metabolites they form, epoxyoctadecenoic acids (EpOMEs).Researchers compared healthy mice and mice with colon cancer by performing metabolomics, a comprehensive and complex analysis of metabolites, which are produced when food and chemicals are broken down.The researchers found that certain fatty acid metabolites were more abundant in colon cancer. "If a mouse has colon ...
Dietary self-monitoring less disagreeable than perceived
One of the best predictor of success to losing weight is monitoring and recording calorie and fat intake throughout the day. However dietary self-monitoring is widely viewed as so unpleasant and time-consuming, many would-be weight-losers can't muster the will power to do it.A new research, to be published in the March issue of Obesity suggests that the reality of dietary self-monitoring may be far less disagreeable than the perception.The study found that after six months of monitoring their dietary intake, the most successful participants in an online behavioural weight-loss programme spent an average of just 14.6 minutes per day on the activity.Programme participants recorded the calories and fat for all foods and beverages they consumed, as well as the portion sizes and the preparation methods.Conducted by researchers at the University of Vermont and the University of South Carolina, the study is the first to quantify the amount of time that dietary self-monitoring actually takes .
New parents face six years of disrupted sleep: Study
A child's birth has a drastic short-term effect on new mothers' sleep, particularly during the first three months after birth.The research, conducted at the University of Warwick also found sleep duration and satisfaction is decreased up to six years after giving birth for both parents.In the paper 'Long-term effects of pregnancy and childbirth on sleep satisfaction and duration of first-time and experienced mothers and fathers', a collaboration with the German Institute for Economic Research and the West Virginia University studied sleep in 4,659 parents who had a child between 2008 and 2015.During these years parents also reported on their sleep in yearly interviews. In the first 3 months after birth mothers slept on average 1 hour less than before pregnancy while fathers sleep duration decreased by approximately 15 minutes.According to study author Dr Sakari Lemola, "Women tend to experience more sleep disruption than men after the birth of a child reflecting that mothers are still
Early life stress may impact behaviour of this animal
Stress impacts the behaviour in meerkat offsprings at an early age as maternal characteristics can have a profound influence on their children, suggests a new study.
DCW dealt with over 52,000 cases in past three years: Outcome budget
The Delhi Commission for Women (DCW) has dealt with over 52,000 cases in the last three years, which is more than double the numbers addressed in the past eight years, the Outcome Budget of Delhi government Monday said. The Outcome Budget was presented by Deputy Chief Minister Manish Sisodia in the Delhi Assembly. It said between 2015-18, a total of 52,473 cases were addressed by the DCW in comparison to 20,000 cases dealt between 2007-15. Twenty-four programmes were included in the Women and Child Development department in 2018-19, it said. The report also said that 101 'Anganwadi Hub Centres have been set-up by merging 357 'Anganwadi' centres on the pattern of pre-school delivery system. It pointed out that spacious and vibrant 'mohalla playschools' for children aged between 3-6 years from economically disadvantaged background has also been developed. As many as 10,897 'Anganwadi' centres are presently providing nutrition, vaccination, health services and pre-school activities under
Fortis writes to Sebi for arrest of Singh brothers
Fortis Healthcare has said it has asked markets regulator Sebi to initiate legal proceedings, including arrest of its former promoters Singh borthers, to recover Rs 472 crore from them and related entities. In an application to Sebi for the recovery of the amount, Fortis Healthcare and Fortis Hospitals have asked for the invocation of Section 28 A of the Act to recover the amounts from Malvinder Mohan Singh, Shivinder Mohan Singh, RHC holdings Pvt Ltd, Shivi Holdings Pvt Ltd, Malav Holdings Pvt Ltd, Religare Finvest Ltd, Best Healthcare Pvt Ltd, Fern healthcare Pvt Ltd and Modland Wears Pvt Ltd. Fortis Healthcare has also asked the Securities and Exchange Board of India (Sebi) for a personal hearing on the matter. Commenting on the development, Fortis Healthcare Ltd Chairman Ravi Rajagopal said: "Once SEBI order was received in Oct 2018, then the revised version in Dec 2018, we began legal proceedings to recover the money as per the directive in the order. All the nine ...
Here's how a certain bacterium communicates and makes us sick
Researchers have now discovered the unique way in which a type of Gram-negative bacterium delivers the toxins that make people sick. According to the Binghamton University, State University of New York study, understanding this mechanism may help design better ways to block and eventually control those debilitating toxins.Authors Assistant Professor Xin Yong, graduate student Ao Li and Associate Professor Jeffrey W. Schertzer published their findings in the Journal of Biological Chemistry.The study looked at how bacteria communicate via the transportation of small molecules. Yong and Schertzer explained that communication molecules stimulate the production of outer membrane vesicles. These small packages then bud off from the surface of the bacterium and contain highly concentrated toxins.Yong and Schertzer decided to work together on a model to understand more about how the communication molecule inserts itself into the membrane of bacteria in order to physically stimulate the ...
Sperm quality unaffected by one course of chemotherapy for early testicular cancer
A new study now finds that men with early stage testicular cancer can safely receive one course of chemotherapy or radiotherapy after surgery without it having long-term effect on their sperm count. The study was published in the cancer journal Annals of Oncology.While it is known that several rounds of chemotherapy or high doses of radiotherapy given to men with more advanced testicular cancer can reduce sperm count and concentration, it has been unclear, until now, whether a single cycle of chemotherapy or radiotherapy would have a similar effect in men with stage I disease.Speaking about it, lead author Dr Kristina Weibring said, "We wanted to examine in more detail if postoperative treatment, given to decrease the risk of recurrence after the removal of the tumorous testicle, would affect the sperm count and sperm concentration long term in testicular cancer patients with no spread of the disease. To our knowledge, no such study has been done before."Weibring added, "This is ...
Lupin gets USFDA nod for generic drug to treat inflammation
Drug firm Lupin Monday said it has received approval from the US health regulator to market Methylprednisolone tablets used for treatment of inflammation in many conditions. It has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Pharmacia and Upjohn Company's Medrol tablets, Lupin said in a statement. The drug is indicated to treat endocrine and rheumatic disorders among others. As per IQVIA MAT December 2018 data, the company said, Methylprednisolone tablets had annual sales of around USD 114.3 million in the US. Lupin shares Monday settled marginally down at Rs 776 apiece on the BSE.